Targeting EpCAM (CD326) for immunotherapy in hepatoblastoma

Armeanu-Ebinger, Sorin; Hoh, Alexander; Wenz, Julia; Fuchs, Joerg

dc.contributor.author	Armeanu-Ebinger, Sorin
dc.contributor.author	Hoh, Alexander
dc.contributor.author	Wenz, Julia
dc.contributor.author	Fuchs, Jörg
dc.date.accessioned	2013-11-29T14:32:08Z
dc.date.available	2013-11-29T14:32:08Z
dc.date.issued	2013
dc.identifier.issn	2162-4011
dc.identifier.uri	http://hdl.handle.net/10900/38397
dc.language.iso	en	de_DE
dc.publisher	Landes Bioscience	de_DE
dc.relation.uri	http://dx.doi.org/10.4161/onci.22620	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	570	de_DE
dc.subject.ddc	610	de_DE
dc.title	Targeting EpCAM (CD326) for immunotherapy in hepatoblastoma	de_DE
dc.type	Article	de_DE
utue.quellen.id	20130911224530_02180	de_DE
utue.personen.roh	Armeanu-Ebinger, Sorin
utue.personen.roh	Hoh, Alexander
utue.personen.roh	Wenz, Julia
utue.personen.roh	Fuchs, Joerg
dcterms.isPartOf.ZSTitelID	Oncoimmunology	de_DE
dcterms.isPartOf.ZS-Issue	Article e22620	de_DE
dcterms.isPartOf.ZS-Volume	2	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE